THE SERUM BACTERICIDAL ACTIVITY OF LATAMOXEF (MOXALACTAM), CEFOPERAZONE AND CEFOTAXIME

被引:3
作者
MCNAMEE, W
DRUSANO, GL
TATEM, BA
STANDIFORD, HC
机构
[1] VET ADM MED CTR,INFECT DIS SECT,BALTIMORE,MD 21218
[2] UNIV MARYLAND,SCH MED,BALTIMORE,MD 21201
关键词
D O I
10.1093/jac/14.5.491
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:491 / 497
页数:7
相关论文
共 15 条
[1]   ANTIMICROBIAL SYNERGISM IN THERAPY OF GRAM-NEGATIVE ROD BACTEREMIA [J].
ANDERSON, ET ;
YOUNG, LS ;
HEWITT, WL .
CHEMOTHERAPY, 1978, 24 (01) :45-54
[2]   SIMPLIFIED ACCURATE METHOD FOR ANTIBIOTIC ASSAY OF CLINICAL SPECIMENS [J].
BENNETT, JV ;
BRODIE, JL ;
BENNER, EJ ;
KIRBY, WMM .
APPLIED MICROBIOLOGY, 1966, 14 (02) :170-&
[3]  
BOLICAR R, 1981, 21ST INT C ANT AG CH
[4]  
BROWN AE, 1981, 21ST INT C ANT AG CH
[5]   ANTIBACTERIAL ACTIVITY IN SERUM AND URINE AS A THERAPEUTIC GUIDE IN BACTERIAL INFECTIONS [J].
KLASTERS.J ;
DANEAU, D ;
SWINGS, G ;
WEERTS, D .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (02) :187-193
[6]   COMPARATIVE EFFECTIVENESS OF COMBINATIONS OF AMIKACIN WITH PENICILLIN-G AND AMIKACIN WITH CARBENICILLIN IN GRAM-NEGATIVE SEPTICEMIA - DOUBLE-BLIND CLINICAL-TRIAL [J].
KLASTERSKY, J ;
HENSGENS, C ;
MEUNIERCARPENTIER, F .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S433-S440
[7]   CLINICAL SIGNIFICANCE OF IN-VITRO SYNERGISM BETWEEN ANTIBIOTICS IN GRAM-NEGATIVE INFECTIONS [J].
KLASTERSKY, J ;
CAPPEL, R ;
DANEAU, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 2 (06) :470-+
[8]   COMPARATIVE INVITRO SYNERGISTIC ACTIVITY OF NEW BETA-LACTAM ANTI-MICROBIAL AGENTS AND AMIKACIN AGAINST PSEUDOMONAS-AERUGINOSA AND SERRATIA-MARCESCENS [J].
KURTZ, TO ;
WINSTON, DJ ;
BRUCKNER, DA ;
MARTIN, WJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (02) :239-243
[9]   COMPARATIVE INVITRO ACTIVITY OF MOXALACTAM, CEFOTAXIME, CEFOPERAZONE, PIPERACILLIN, AND AMINOGLYCOSIDES AGAINST GRAM-NEGATIVE BACILLI [J].
KURTZ, TO ;
WINSTON, DJ ;
HINDLER, JA ;
YOUNG, LS ;
HEWITT, WL ;
MARTIN, WJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (04) :645-648
[10]   SERUM BACTERICIDAL ACTIVITY OF MOXALACTAM AND CEFOTAXIME WITH AND WITHOUT TOBRAMYCIN AGAINST PSEUDOMONAS-AERUGINOSA AND STAPHYLOCOCCUS-AUREUS [J].
LAGAST, H ;
ZINNER, SH ;
KLASTERSKY, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (04) :539-541